| Literature DB >> 32127629 |
Ci-Xiu Li1,2,3, Wei Li4, Jun Zhou5, Bing Zhang6, Yan Feng1, Chang-Ping Xu1, Yi-Yu Lu1, Edward C Holmes7, Mang Shi8.
Abstract
The diversity of pathogens associated with acute respiratory infection (ARI) makes diagnosis challenging. Traditional pathogen screening tests have a limited detection range and provide little additional information. We used total RNA sequencing ("meta-transcriptomics") to reveal the full spectrum of microbes associated with paediatric ARI. Throat swabs were collected from 48 paediatric ARI patients and 7 healthy controls. Samples were subjected to meta-transcriptomics to determine the presence and abundance of viral, bacterial, and eukaryotic pathogens, and to reveal mixed infections, pathogen genotypes/subtypes, evolutionary origins, epidemiological history, and antimicrobial resistance. We identified 11 RNA viruses, 4 DNA viruses, 4 species of bacteria, and 1 fungus. While most are known to cause ARIs, others, such as echovirus 6, are rarely associated with respiratory disease. Co-infection of viruses and bacteria and of multiple viruses were commonplace (9/48), with one patient harboring 5 different pathogens, and genome sequence data revealed large intra-species diversity. Expressed resistance against eight classes of antibiotic was detected, with those for MLS, Bla, Tet, Phe at relatively high abundance. In summary, we used a simple total RNA sequencing approach to reveal the complex polymicrobial infectome in ARI. This provided comprehensive and clinically informative information relevant to understanding respiratory disease.Entities:
Mesh:
Year: 2020 PMID: 32127629 PMCID: PMC7054269 DOI: 10.1038/s41598-020-60992-6
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Clinical information on the paediatric ARI cohort used in this study. M = male; F = Female; HFMD = Hand, foot and mouth disease. Each positive diagnostic result or symptom is denoted with a “ + ”.
Figure 2Diversity and abundance of viruses identified in this study. (A) Number of virus species in each case, including RNA viruses (blue) and DNA viruses (orange). (B) Heatmap showing the abundance level of different virus species within each library. The abundance level of reads was normalized to unique reads mapped per million input reads (RPM). HRV-A: human rhinovirus A; HRV-C: human rhinovirus C; Echo6: echovirus E6; HCoV-HKU1: human coronavirus HKU1; InfA(H1N1): influenza A virus H1N1; InfB: influenza B virus; HMPV: human metapneumovirus; HRSV: human respiratory syncytial virus; MeV: measles virus; HPIV-3: human parainfluenza virus 3; HCMV: human cytomegalovirus; EBV: Epstein-Barr virus; HSV1: herpes simples virus 1; picobirna: members of the family Picobirnaviridae; papilloma: members of the family Papillomaviridae.
Figure 3Intra-species diversity and phylogenetic relationships of RNA viruses identified in this study. Viruses identified here are marked in red and highlighted with a red solid circle, whereas those representing the background phylogenetic diversity are shown in black. All horizontal branch lengths are scaled to the number of nucleotide substitutions per site, and trees are mid-point rooted for clarity.
Figure 4Phylogenetic analysis of Haemophilus influenzae (A), Klebsiella pneumoniae (B), Streptococcus pneumoniae (C) and Moraxella catarrhalis (D), based on the concatenated multigene data set. Within each phylogeny, the bacteria identified in this study are marked in red and highlighted with a red solid circle. All horizontal branch lengths are scaled to the number of nucleotide substitutions per site, and trees are mid-point rooted for clarity.
Identification of virus, bacteria, and fungi pathogens in ARI using meta-transcriptomics.
| No. | Initial Diagnosis | Syndrome* | Initial pathogen screening (Not performed in this study) | Final diagnosis | |
|---|---|---|---|---|---|
| Virus | Bacteria/Fungus | ||||
| 1 | Bronchopneumonia Agranulocytosis | F; C; P; PH | Human respiratory syncytial virus + Human cytomegalovirus+ | ||
| 2 | Bronchopneumonia | P; S; PH | Human rhinovirus C++ | ||
| 3 | Pneumonia | C; NO | Human cytomegalovirus (PCR) | Human rhinovirus A++ | |
| 4 | Bronchopneumonia | C; NO; W; PH | Respiratory syncytial virus (PCR) | Human respiratory syncytial virus++ + Human cytomegalovirus | |
| 5 | Bronchopneumonia | F; C; W | Human metapneumovirus+ | ||
| 6 | Bronchopneumonia | F; C; P; W; PH | Human metapneumovirus Human parainfluenza virus 3+ | ||
| 7 | Bronchopneumonia | F; C; P; S; NO; W; PH | Human metapneumovirus++ | ||
| 8 | Bronchopneumonia | F; C; P; W; PH | Human rhinovirus C + Human metapneumovirus + + Measles virus + Human parainfluenza virus 3 + + + Human cytomegalovirus | ||
| 10 | Acute upper respiratory tract infection Acute lymphadenitis | C; PH | Epstein–Barr virus (PCR, Antibody) | Epstein–Barr virus+ | |
| 11 | Bronchopneumonia | F; C; P; S; NO; PH | Influenza A (H1N1) | ||
| 12 | Bronchopneumonia HFMD | F; C; W; OH; PH | Yeast (Culture) | ||
| 13 | Pneumonia Sepsis | F; D | Gram positive bacteria | ||
| 15 | Bronchopneumonia | F; C; P; S; NO | Human cytomegalovirus (Antibody) | Human cytomegalovirus+ | |
| 18 | Bronchopneumonia Influenza | F; C; P; PH | Influenza B virus (PCR) | ||
| 19 | Acute tonsillitis Influenza | F; C; R; OH; PH | Enterovirus (universal) positive (PCR) | Influenza B virus | |
| 20 | Bronchopneumonia Agranulocytosis | F; C; P; PH | |||
| 22 | Bronchopneumonia | F; C; P; PH | Echovirus E6+++ | ||
| 23 | Acute upper respiratory tract infection Otitis media | F; C; PH | Influenza B virus | ||
| 30 | Bronchopneumonia | F; C; P; W; PH | Human coronavirus HKU1 Human metapneumovirus | ||
| 31 | Bronchopneumonia | F; C; P; PH | Human cytomegalovirus+ | ||
| 33 | Bronchopneumonia Agranulocytosis | F; C; P; PH | Influenza B virus | ||
| 34 | Bronchopneumonia | F; C; P; W | Human metapneumovirus++ | ||
| 36 | Bronchopneumonia Acute herpangina | F; C; S; PH | Human coronavirus HKU1+ | ||
| 38 | Bronchopneumonia Agranulocytosis | F; C; P; S; NO; PH | Influenza B virus Human parainfluenza virus 3+ | ||
| 39 | Bronchopneumonia | F; C; P; PH | Human rhinovirus A+ + Human metapneumovirus + + | ||
| 40 | Acute tonsillitis Acute urticaria | F; C; P; S; NO; R; PH | Human metapneumovirus + | ||
| 43 | Bronchopneumonia Syncope | F; C; P; W | Human respiratory syncytial virus + | ||
| 48 | Acute bronchitis | C; P | Human metapneumovirus + + | ||
*F, Fever; C, Cough; P, Phlegm; S, Snivel; NO, Nasal obstruction; W, Wheeze; R, Rash; OH, Oral herpes; PH, Pharynx hyperemia; D, Diarrhea.
Figure 5Identification of a novel fungal species Candida sp. Phylogenetic trees are based on the cytochrome c oxidase subunit 1 (COX 1) gene (A) and the internal transcribed spacer region (ITS) (B). Species identified in this study are marked in red. (C) Signature sequences of a short fragment (35 bp) of the internal transcribed spacer region 2 (ITS2). Sequences are aligned against the 35 bp signature of the most common C. albicans variant (C. albicans 1) (34). Coloured letters indicate positions in which the sequence differs from that of C. albicans 1. The red arrow indicates position that species identified in this study differs from that of C. albicans 1.
Figure 6Antibiotic resistance genes expressed in the samples collected from ARI patients and control cases. (A) Diversity of resistance genes observed in each library. Tmt = Trimethoprim, Tet = Tetracyclines, Sul = Sulfonamides, Phe = Phenicols, MLS = Macrolide-Lincosamide-Streptogramin, Flq = Fluoroquinolones, Bla = β- lactamases, and AGly = Aminoglycosides. (B) The abundance level of each antibiotic resistance gene identified in this study. These genes are grouped into 8 classes based on their resistance target and their abundance levels were measured using RPM.